Journal profile · Allergy
Iranian Journal of Allergy Asthma and Immunology
ISSN 1735-1502 · eISSN 1735-5249 · Tehran University of Medical Sciences · IRAN · Quarterly · Founded 2000
Iranian Journal of Allergy Asthma and Immunology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.44; fully open access; APC about USD 300; median 81 days to acceptance (104 articles, last 24 months); community-reported acceptance: easy; 87 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Iranian Journal of Allergy Asthma and Immunology is published by Tehran University of Medical Sciences and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Immunodeficiency and Autoimmune Disorders, together about 24.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The Iranian Journal of Allergy, Asthma and Immunology (IJAAI) is an internationally recognized peer-reviewed scientific and research journal. It is dedicated to the dissemination of original papers, selected review articles, case-based reviews, and other articles of special significance within the realms of asthma, allergy, and immunology. As an official publication of the Iranian Society of Asthma and Allergy (ISAA), IJAAI enjoys the backing of the Immunology, Asthma and Allergy Research Institute (IAARI) and is proudly published by Tehran University of Medical Sciences (TUMS). The journal is committed to offering its readers the utmost quality content, achieved through meticulous peer reviews and expert editorial insights. All contributions are presented in the English language, ensuring a broad international reach.
From the journal's Aims & Scope
Research area (LetPub): Allergy
Editor-in-chief Masoud MovahediPublisher website
Editorial board by country: none in mainland China; most named Iran 44, United States 7, Italy 3, United Kingdom 2, Japan 2 (69 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine11.1%
- Allergic Rhinitis and SensitizationMedicine7%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology6.7%
- Immune Cell Function and InteractionImmunology and Microbiology6.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology6.4%
- COVID-19 Clinical Research StudiesMedicine6%
- Food Allergy and Anaphylaxis ResearchMedicine4.9%
- Cancer Immunotherapy and BiomarkersMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.44LetPub ·
- Impact factor (publisher) 2025
- 1.5Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher) 2025
- 2.2Publisher website ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.41LetPub ·
- h-index
- 21LetPub ·
- h-index
- 21OpenAlex ·
- i10-index
- 89OpenAlex ·
- 2-year mean citedness
- 0.76OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 98.48%LetPub ·
Volume
- Articles per year
- 73LetPub ·
- Articles per year (publisher)
- 2,000Publisher website ·
Articles by year OpenAlex count · 658 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 88 | 88 | 1 |
| 2025 | 87 | 87 | 53 |
| 2024 | 76 | 76 | 136 |
| 2023 | 55 | 55 | 235 |
| 2022 | 72 | 72 | 305 |
| 2021 | 82 | 82 | 520 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
81 daysMedian, submission to acceptance · P25–P75 49 days – 141 days
- Acceptance to online
- median 186 days (104 articles)
- Submission to online
- median 279 days
- Sample
- 104 articles with submission and acceptance dates (184 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 56 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 300 | Yes | CC BY-NC | |
| OpenAlex | USD 300 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Cover letter
- Required
Article types accepted7, with length limits
- case reportAn Unexpected Association of a Novel MYOF Variant with Generalized Myopathy and HAE-nl-C1-INH Zahra Alizadeh , Atefe Alirezaee , Laleh Habibi , Abbas Tafakhori …Length not stated
- case-based reviewscase-based reviewsLength not stated
- letter to the editorVaricella-associated Pseudofasciitis: A Postviral Hyperinflammatory Soft Tissue Reaction Mimicking Necrotizing Fasciitis in Children Mahmoud Khodabandeh XML | P…Length not stated
- original articlearting with the title page. The text of original articles amounting to a maximum of 3000 words (excluding Abstract, References, Figures, and Tables) shoulmain text ≤ 3,000 words
- original papersseeks to publish original papersLength not stated
- review articletion process for the systematic review. Review articles: These documents generally fall within the word range of 4,000 to 7,000 words (less than 4000 words' pap…main text ≤ 7,000 words
- review articlesselected review articlesLength not stated
Policy excerpts from the journal's websiteAuthorship, Publication ethics, Peer review
- Authorship
Instructions to Authors in accordance with ICMJE Uniform Requirements. Model summary
The Instructions to Authors of this journal are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (icmje.org).
Source ↗Publisher website ·- Publication ethics
Editorial freedom per WAME; member of COPE; adopts COPE guidelines for ethical misbehavior. Model summary
The IJAAI uses the World Association of Medical Editors’ definition of editorial freedom and is a member of the Committee on Publication Ethics (COPE). The journal adopts COPE’s guidelines upon encounter with ethical misbehavior.
Source ↗Publisher website ·- Peer review
Cover letter mandatory; otherwise fast rejection. Model summary
A cover letter is mandatory to be uploaded as a supplementary file during the submission; otherwise, the manuscript will be fast rejected.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Tehran University of Medical Sciences
- Country or region
- IRAN
- Language
- English
- Frequency
- Quarterly
- Founded
- 2000
- ISSN
- 1735-1502
- Electronic ISSN
- 1735-5249
- Latest issue on the website
- Volume 25, Issue S11 (2026)
- Official links
FAQ
Frequently asked questions about Iranian Journal of Allergy Asthma and Immunology
What CAS zone is Iranian Journal of Allergy Asthma and Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Iranian Journal of Allergy Asthma and Immunology is in Zone 4 of Medicine, and in Zone 4 of the minor category Allergy / Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Iranian Journal of Allergy Asthma and Immunology?
The latest impact factor listed by LetPub is 1.44; CiteScore 2.2, h-index 21.
How long does peer review take at Iranian Journal of Allergy Asthma and Immunology?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 49–141 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Iranian Journal of Allergy Asthma and Immunology based?
Of the 69 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (44), United States (7) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Iranian Journal of Allergy Asthma and Immunology?
According to LetPub and DOAJ records, Iranian Journal of Allergy Asthma and Immunology is indexed in SCIE, Scopus and DOAJ.
Is Iranian Journal of Allergy Asthma and Immunology open access, and what is the APC?
Iranian Journal of Allergy Asthma and Immunology is a fully open-access journal. APC about USD 300.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .